Advanced Cancer Treatment
Minimally Invasive Solutions for Hard-to-Treat Cancers
Embio Medical develops proprietary catheter platform technologies using electroporation to transform the treatment of severe and difficult-to-access tumors.
Our Mission
Safer, earlier intervention for hard-to-treat cancers
Our mission is to make cancer treatment safer, more targeted, and less invasive, through precision catheter-based therapies – starting with pancreatic cancer, one of the hardest cancers to treat today.
Our Technology
Designed for Precision. Built for Impact.
Embio's catheter is engineered to deliver safer, earlier, and more effective cancer treatment. The technology is based on an extension of CathPrint's e-Shaft concept and our patent-pending inventions. The main feature is that it allows an arbitrary number of electrodes for the same catheter size. This enables an extremely low electroporation pulse voltage rendering high procedure safety.
- Ultra-thin Design — Extremely small diameter enables deep duct access
- Flexible Electrodes — Customisable positioning for precision therapy
- "Bulge" Mechanism — Ensures full tissue contact for effective treatment
- Dual Therapy — Supports IRE and ECT for versatile applications
Our Products
Proprietary Catheter Platforms
Two complementary platforms designed to deliver electroporation therapy through different clinical approaches.
DuCath™
Intraductal Electroporation Catheter
The DuCath is designed primarily for a focus on pancreatic & bile duct pre-cancerous lesions.
- Ultra-thin catheter engineered for safe navigation through fragile duct anatomy
- Dense ring electrode layout
- Enables precise electroporation directly at the disease site
- Designed to integrate seamlessly into existing endoscopic workflows
Primary focus: Pancreatic & bile duct cancers
PonCath™
Pediatric Brainstem Tumor Electroporation Catheter
The PonCath enables electroporation treatment of pediatric brainstem tumours, including diffuse intrinsic pontine glioma (DIPG) (concept).
- Next-generation, ultra-thin stereotactic probe concept for treating highly sensitive neural structures
- Designed for extreme precision in delicate brain anatomy
- Enables electroporation where surgery and thermal ablation are not viable
Primary focus: Pediatric brainstem tumours, including diffuse intrinsic pontine glioma (DIPG)
PenCath™
Penetrating Duct-Wall Electroporation Catheter
- Enables targeted treatment of tumours located adjacent to, but not inside the duct lumen
- Allows localised treatment while preserving critical nearby structures
- Designed for highly constrained anatomical environments
- Addresses limitations of conventional ablation technologies
Primary focus: Pancreatic and bile duct tumours that are inaccessible from within the lumen alone